Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy
β Scribed by J. M. Zimmet; J. M. Hare
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 281 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0300-8428
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The incidence of lung fibrosis increases with age. Aging is associated with modifications in the intracellular and extracellular environment including alteration of the extracellular matrix, imbalance of the redox state, accumulation of senescent cells and potential alteration of the re
## Abstract Two chondrogenic factors, Dex and TGFβ__Ξ²__1, were incorporated into PLGA scaffolds and their chondrogenic potential was evaluated. The Dexβloaded PLGA scaffold was grafted with AA and heparin, the heparinβimmobilized one was then reacted with TGFβ__Ξ²__1, yielding a PLGA/DexβTGF (PLGA/D
## Abstract Mesenchymal stem cells (MSCs) are immunoprivileged and the allogeneic MSCs implantation has been used to facilitate tissue repairs such as bone and cartilage defect. The present study aimed to investigate the feasibility of xenogeneic MSCs implantation. Green fluorescent protein (GFP) t
## Abstract Mesenchymal stem cells derived from human bone marrow (hBMβMSCs) can differentiate into chondrogenic cells for the potential treatment of injured articular cartilage. To evaluate agarose gels as a supportive material for chondrogenesis of hBMβMSCs, this study examined chondrogenesis of